Phase II trial of palbociclib in patients with metastatic urothelial cancer after failure of first-line chemotherapy

por Rose, Tracy L., Chism, David D., Alva, Ajjai S., Deal, Allison M., Maygarden, Susan J., Whang, Young E., Kardos, Jordan, Drier, Anthony, Basch, Ethan, Godley, Paul A., Dunn, Mary W., Kim, William Y., Milowsky, Matthew I.
Publicado 2018

A real-world evaluation of radium-223 in combination with abiraterone or enzalutamide for the treatment of metastatic castration-resistant prostate cancer

por Kim, Stephanie I., Szeto, Andy H., Morgan, Katherine P., Brower, Blaine, Dunn, Mary W., Khandani, Amir H., Godley, Paul A., Rose, Tracy L., Basch, Ethan M., Milowsky, Matthew I., Whang, Young E., Crona, Daniel J.
Publicado 2021

Correction: A real-world evaluation of radium-223 in combination with abiraterone or enzalutamide for the treatment of metastatic castration-resistant prostate cancer

por Kim, Stephanie I., Szeto, Andy H., Morgan, Katherine P., Brower, Blaine, Dunn, Mary W., Khandani, Amir H., Godley, Paul A., Rose, Tracy L., Basch, Ethan M., Milowsky, Matthew I., Whang, Young E, Crona, Daniel J
Publicado 2021